WHO ICTRP trial
Study of early warning, diagnosis and prevention of coronary heart disease based…
ChiCTR2200056788 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200056788 |
|---|---|
| Public title | Study of early warning, diagnosis and prevention of coronary heart disease based on novel biological factors |
| Scientific title | The mechanism of sRAGE on myocardial ischemia-reperfusion injury by regulating Treg cells |
| Primary sponsor | Beijing Tongren Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Coronary atherosclerotic heart disease |
| Interventions | Not applicable:Not applicable |
| Registration date | Feb 17, 2022 |
| Target size | Not applicable:15000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: